Valiant Evo US Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

March 2, 2023

Conditions
Aortic Aneurysm, Thoracic
Interventions
DEVICE

Valiant Evo Thoracic Stent Graft System

Procedure: thoracic endovascular aneurysm repair (TEVAR)

Trial Locations (21)

12208

Albany Medical Center, Albany

19104

University of Pennsylvania, Philadelphia

20010

Medstar Washington Hospital Center, Washington D.C.

22042

Inova Fairfax Hospital, Falls Church

22908

University of Virginia Medical Center, Charlottesville

23507

Sentara Norfolk General Hospital, Norfolk

27514

University of North Carolina, Chapel Hill

27710

Duke University Medical Center, Durham

28203

Carolinas Medical Center, Charlotte

30322

Emory University Hospital, Atlanta

32610

University of Florida, Gainesville

43210

Ohio State University, Columbus

43214

OhioHealth Riverside Methodist Hospital, Columbus

44195

Cleveland Clinic, Cleveland

48109

University of Michigan Health System, Ann Arbor

55455

University of Minnesota Medical Center, Minneapolis

63110

Barnes Jewish Hospital, St Louis

75093

The Heart Hospital Baylor Plano, Plano

77030

Memorial Hermann Texas Medical Center, Houston

85006

Abrazo Arizona Heart Institute, Phoenix

94305

Stanford Hospital, Stanford

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY

NCT02652949 - Valiant Evo US Clinical Trial | Biotech Hunter | Biotech Hunter